1577
The U.S. Food and Drug Administration (FDA) has issued a safety communication advising against the use of smartwatches or smart rings that claim to measure blood glucose levels without piercing the skin. This warning is directed at consumers, patients, caregivers, and healthcare providers, emphasizing that the FDA has not authorized, cleared, or approved any such devices for this purpose. The alert distinguishes these products from smartwatch applications that display data from FDA-authorized devices, such as continuous glucose monitoring devices (CGMs), which do require skin piercing. The...
2200
Continuous Glucose Monitoring (CGM) devices are advanced tools used primarily by individuals with diabetes to continuously track glucose levels in their body. These devices offer a significant advantage over traditional blood glucose meters by providing real-time data on glucose trends around the clock. A CGM system typically consists of a small sensor, usually placed under the skin, which...